Hologic, Inc. (HOLX) Reports In-Line Q2 EPS; Guides Q3 Below Views
Tweet
Share
E-mailGet Alerts HOLX Hot Sheet
Price: $76.01 --0%
Financial Fact:
Selling and marketing: 105.9M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Selling and marketing: 105.9M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Hologic, Inc. (NASDAQ: HOLX) reported Q2 EPS of $0.33, in-line with the analyst estimate of $0.33. Revenue for the quarter came in at $471.2 million versus the consensus estimate of $474.03 million.
Hologic, Inc. sees Q3 2012 EPS of $0.34, versus the consensus of $0.35. Hologic, Inc. sees Q3 2012 revenue of $475-$480 million, versus the consensus of $481.97 million.
Reaffirms FY12 outlook.
For earnings history and earnings-related data on Hologic, Inc. (HOLX) click here.
Hologic, Inc. sees Q3 2012 EPS of $0.34, versus the consensus of $0.35. Hologic, Inc. sees Q3 2012 revenue of $475-$480 million, versus the consensus of $481.97 million.
Reaffirms FY12 outlook.
For earnings history and earnings-related data on Hologic, Inc. (HOLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- BMO starts chip stocks coverage: Here are its preferred picks
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
